Severity
Critical
FDA Drug recall · Reported February 5, 2014
Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used t…
Iq Formulations, LLC recalled Hydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules pe… - a critical-severity action.
Hydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules pe… was recalled by Iq Formulations, LLC in February 5, 2014. Reason: Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic c…. Check the official notice for the remedy. Verify recall #D-1050-2014 with the FDA Drug before acting.
The recall
Iq Formulations, LLC issued this critical-severity FDA Drug recall-Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic c….
Sourced from official FDA Drug enforcement records. Verify recall #D-1050-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1050-2014) was formally reported on February 5, 2014, with the manufacturer initiating the action on November 4, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Iq Formulations, LLC is listed as the recalling firm, operating out of Sunrise, FL. The number of affected units is not disclosed in the agency filing, which is common for drug and food recalls where lot-level tracking supersedes unit counts.
The documented reason for this recall is: Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used to treat edema, making it an unapproved n… Distribution data in the federal record shows the product reached: Nationwide, Hawaii and Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
Unknown
Related Recalls
6
5 from same agency
Hydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules per bottle, Dietary Supplement, Manufactured and Distributed by Metabolic Nutrition, Sunrise, Florida, www.metabolicnutrition.com
Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used to treat edema, making it an unapproved new drug
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-1050-2014 |
| Date reported | February 5, 2014 |
| Date initiated | November 4, 2013 |
| Recalling firm | Iq Formulations, LLC |
| Firm location | Sunrise, FL |
| Affected scope | Not disclosed |
| Distribution | Nationwide, Hawaii and Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 5, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.